HCA Healthcare Inc (NYSE: HCA) has recently enjoyed significant positive changes in fundamentals: the consensus estimate for December, 2025 increased significantly, the consensus estimate for December, 2024 increased significantly, and significant quarterly earnings acceleration occurred.
Recent meaningful positive changes in investment behavior have benefitted HCA Healthcare Inc (NYSE: HCA): positive upside/downside volume developed.
The stock is currently unrated.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, HCA is expected to be an important Value Eraser.
HCA Healthcare is currently unrated.
Recent Price Action
On 8/5/24, HCA Healthcare Inc (NYSE: HCA) stock declined modestly by -1.7%, closing at $350.18. NORMAL trading volume accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -1.3% during the last week.
Be the first to comment